PL2979096T3 - Integryna alfa-v-beta-6 do diagnozowania/prognozowania raka okrężnicy i odbytnicy - Google Patents

Integryna alfa-v-beta-6 do diagnozowania/prognozowania raka okrężnicy i odbytnicy

Info

Publication number
PL2979096T3
PL2979096T3 PL14712691T PL14712691T PL2979096T3 PL 2979096 T3 PL2979096 T3 PL 2979096T3 PL 14712691 T PL14712691 T PL 14712691T PL 14712691 T PL14712691 T PL 14712691T PL 2979096 T3 PL2979096 T3 PL 2979096T3
Authority
PL
Poland
Prior art keywords
prognosis
diagnosis
beta
colorectal carcinoma
integrin alpha
Prior art date
Application number
PL14712691T
Other languages
English (en)
Inventor
Gerhard Rogler
Michael Scharl
Original Assignee
Universität Zürich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47997214&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2979096(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Universität Zürich filed Critical Universität Zürich
Publication of PL2979096T3 publication Critical patent/PL2979096T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL14712691T 2013-03-27 2014-03-27 Integryna alfa-v-beta-6 do diagnozowania/prognozowania raka okrężnicy i odbytnicy PL2979096T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13161489.3A EP2784511A1 (en) 2013-03-27 2013-03-27 Integrin alpha-v-beta6 for diagnosis/prognosis of colorectal carcinoma
PCT/EP2014/056167 WO2014154809A1 (en) 2013-03-27 2014-03-27 INTERGRIN ανβ6 FOR DIAGNOSIS/PROGNOSIS OF COLORECTAL CARCINOMA
EP14712691.6A EP2979096B1 (en) 2013-03-27 2014-03-27 Integrin alpha-v-beta 6 for diagnosis/prognosis of colorectal carcinoma

Publications (1)

Publication Number Publication Date
PL2979096T3 true PL2979096T3 (pl) 2018-03-30

Family

ID=47997214

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14712691T PL2979096T3 (pl) 2013-03-27 2014-03-27 Integryna alfa-v-beta-6 do diagnozowania/prognozowania raka okrężnicy i odbytnicy

Country Status (5)

Country Link
US (2) US20160047813A1 (pl)
EP (2) EP2784511A1 (pl)
ES (1) ES2634629T3 (pl)
PL (1) PL2979096T3 (pl)
WO (1) WO2014154809A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106324236B (zh) * 2015-06-28 2018-10-19 上海市第一人民医院 基于纳米均相时间分辨荧光免疫与液滴微流控技术的检测生物大分子的方法
WO2017120304A1 (en) 2016-01-08 2017-07-13 Commscope Technologies Llc Improving azimuth determination accuracy using multiple gnss antennas
US11046685B2 (en) 2017-02-28 2021-06-29 Morphic Therapeutic, Inc. Inhibitors of (α-v)(β-6) integrin
EP4159727B1 (en) 2017-02-28 2026-04-08 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin
WO2020047208A1 (en) 2018-08-29 2020-03-05 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin
PT3844162T (pt) 2018-08-29 2025-03-28 Morphic Therapeutic Inc Inibidores da integrina alfa v beta6
AU2019327475B2 (en) 2018-08-29 2025-06-05 Morphic Therapeutic, Inc. INHIBITING αV β6 INTEGRIN
EP4048305A1 (en) 2019-10-25 2022-08-31 University of Washington Computational design of alpha(v) beta (6) integrin binding proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
CA2118760C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of colon cancer patients by measurement of nca 50/90 in blood
NZ502546A (en) 1997-08-08 2002-02-01 Univ California Treatment of acute lung injury and fibrosis with antibodies to alpha-v-beta-6
DE19933173A1 (de) 1999-07-15 2001-01-18 Merck Patent Gmbh Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶
WO2008112004A2 (en) 2006-08-03 2008-09-18 Astrazeneca Ab ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF
US20140113310A9 (en) 2008-12-05 2014-04-24 Myriad Genetics, Incorporated Cancer detection markers
WO2010065968A1 (en) 2008-12-05 2010-06-10 Myriad Genetics, Inc. Cancer detection markers

Also Published As

Publication number Publication date
WO2014154809A1 (en) 2014-10-02
ES2634629T3 (es) 2017-09-28
US20180180617A1 (en) 2018-06-28
EP2979096B1 (en) 2017-05-10
US20160047813A1 (en) 2016-02-18
EP2784511A1 (en) 2014-10-01
EP2979096A1 (en) 2016-02-03

Similar Documents

Publication Publication Date Title
GB201320061D0 (en) Materials nad methods for diagnosis and prognosis of liver cancer
SG10201404206PA (en) Sensor probe seal
GB201303936D0 (en) Methods and Compositions for the Diagnosis of Alzheimers Disease
GB201305702D0 (en) Seal segment
GB201322640D0 (en) Rouge AP Detection
SG11201509630PA (en) Asphaltene inhibition
GB2514493B (en) Downhole detection
GB201311651D0 (en) Media sharing
SG11201508544VA (en) Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof
GB201303614D0 (en) Downhole detection
ZA201603259B (en) Determination of the degree of branching
GB201601669D0 (en) Biosensor
GB201312226D0 (en) Improved antibodies
EP3068893A4 (en) Methods and compositions for diagnosis and prognosis of sepsis
GB201514172D0 (en) Improved information sharing
LT2984108T (lt) Anti-s100a7 antikūnai, skirti vėžio gydymui ir diagnozei
EP2972376A4 (en) Methods for determining prognosis of colorectal cancer
GB201306339D0 (en) Biomarkers for prognosis
EP3015428A4 (en) silicon carbide powder
IL244528A0 (en) Lip balm complex
IL244487B (en) A method for the synthesis of irinotecan
GB2530445B (en) Downhole seal
SG11201509438VA (en) Asphaltene inhibition
GB201401001D0 (en) Enzyme function probes
GB201306195D0 (en) Downhole seal